CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 13,294 Value ($000) $56 Avg Close — Range —
Q4 2022
Shares 13,537 Value ($000) $81 Avg Close — Range —
Q3 2022
Shares 11,688 Value ($000) $68 Avg Close — Range —
Q2 2022
Shares 14,237 Value ($000) $85 Avg Close — Range —
Q1 2022
Shares 12,719 Value ($000) $65 Avg Close — Range —
Q4 2021
Shares 13,082 Value ($000) $32 Avg Close — Range —
Q3 2021
Shares 12,877 Value ($000) $38 Avg Close — Range —
Q2 2021
Shares 13,523 Value ($000) $34 Avg Close — Range —
Q1 2021
Shares 11,157 Value ($000) $32 Avg Close — Range —
Q4 2020
Shares 11,120 Value ($000) $36 Avg Close — Range —
Q3 2020
Shares 10,547 Value ($000) $23 Avg Close — Range —
Q2 2020
Shares 11,150 Value ($000) $13 Avg Close — Range —
Q1 2020
Shares 12,046 Value ($000) $11 Avg Close — Range —
Q3 2019
Shares 9,800 Value ($000) $8 Avg Close — Range —